Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Daniel Birnbaum

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7920-9883; OpenAlex author ID A5033716671. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper

Papers 11

  1. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-20-1039↗
  2. Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer-Letter. Co-author DOI 10.1158/1078-0432.ccr-20-1969↗
  3. Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-20-0439↗
  4. XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/jcm8050596↗
  5. Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2018.02.001↗
  6. Prognostic Value of Molecular Subtypes in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000787↗
  7. A 25-gene classifier predicts overall survival in resectable pancreatic cancer. Co-author DOI 10.1186/s12916-017-0936-z↗
  8. Prognostic value of PDL1 expression in pancreatic cancer. Co-author DOI 10.18632/oncotarget.11685↗
  9. Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic Adenocarcinoma. Co-author PMID 27107061↗
  10. The emerging role of the TGFβ tumor suppressor pathway in pancreatic cancer. Last author DOI 10.4161/cc.11.4.19130↗
  11. Genome profiling of pancreatic adenocarcinoma. Co-author DOI 10.1002/gcc.20870↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Jérémie Birnbaum · 11 shared papers, 2011–2021 · strength 0.90
  2. François Bertucci · 9 shared papers, 2016–2021 · strength 0.82
  3. Émilie Mamessier · 8 shared papers, 2011–2019 · strength 0.55
  4. Jean‐Luc Raoul · 4 shared papers, 2016–2017 · strength 0.24
  5. Jean‐Robert Delpéro · 4 shared papers, 2011–2017 · strength 0.19
  6. Marine Gilabert · 3 shared papers, 2016–2017 · strength 0.19
  7. David Tsai Ting · 2 shared papers, 2020–2021 · strength 0.19
  8. Carlos F. Fernandez-del Castillo · 2 shared papers, 2020–2021 · strength 0.19
  9. Andrew Louis Warshaw · 2 shared papers, 2020–2021 · strength 0.19
  10. Thomas P. Hank · 2 shared papers, 2020–2021 · strength 0.19
  11. Sebastian K.S. Begg · 2 shared papers, 2020–2021 · strength 0.19
  12. Mari A. Mino-Kenudson · 2 shared papers, 2020–2021 · strength 0.19
  13. Andrew Scott Liss · 2 shared papers, 2020–2021 · strength 0.19
  14. Keith D. Lillemoe · 2 shared papers, 2020–2021 · strength 0.19
  15. Olivıer Turrini · 3 shared papers, 2011–2016 · strength 0.13
  16. Azfar Neyaz · 1 shared paper, 2021 · strength 0.11
  17. Vikram Deshpande · 1 shared paper, 2021 · strength 0.11
  18. Tobias Keck · 1 shared paper, 2020 · strength 0.08
  19. Kim C. Honselmann · 1 shared paper, 2020 · strength 0.08
  20. Ulrich Friedrich Wellner · 1 shared paper, 2020 · strength 0.08
  21. Matteo Ligorio · 1 shared paper, 2020 · strength 0.08
  22. Cristina Rosa Ferrone · 1 shared paper, 2020 · strength 0.08
  23. Oliver Schilling · 1 shared paper, 2020 · strength 0.08
  24. Max Chaffanet · 2 shared papers, 2011–2016 · strength 0.08
  25. Marc F. Giovannini · 2 shared papers, 2011–2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.